Free Trial

McKesson (MCK) Competitors

McKesson logo
$710.87 -4.87 (-0.68%)
Closing price 03:59 PM Eastern
Extended Trading
$709.33 -1.54 (-0.22%)
As of 07:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MCK vs. HOLX, HQY, HSIC, MMSI, AMN, CRL, HUM, ITGR, WST, and COR

Should you be buying McKesson stock or one of its competitors? The main competitors of McKesson include Hologic (HOLX), HealthEquity (HQY), Henry Schein (HSIC), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Charles River Laboratories International (CRL), Humana (HUM), Integer (ITGR), West Pharmaceutical Services (WST), and Cencora (COR). These companies are all part of the "medical" sector.

McKesson vs. Its Competitors

McKesson (NYSE:MCK) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

85.1% of McKesson shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.1% of McKesson shares are owned by insiders. Comparatively, 1.9% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

McKesson presently has a consensus price target of $710.17, suggesting a potential downside of 0.10%. Hologic has a consensus price target of $77.33, suggesting a potential upside of 20.80%. Given Hologic's higher possible upside, analysts plainly believe Hologic is more favorable than McKesson.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
McKesson
0 Sell rating(s)
3 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.86
Hologic
0 Sell rating(s)
10 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.47

Hologic has a net margin of 13.83% compared to McKesson's net margin of 0.92%. Hologic's return on equity of 19.71% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
McKesson0.92% -201.12% 5.83%
Hologic 13.83%19.71%10.87%

McKesson has a beta of 0.48, meaning that its share price is 52% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.55, meaning that its share price is 45% less volatile than the S&P 500.

In the previous week, McKesson had 28 more articles in the media than Hologic. MarketBeat recorded 44 mentions for McKesson and 16 mentions for Hologic. McKesson's average media sentiment score of 1.14 beat Hologic's score of 1.04 indicating that McKesson is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
McKesson
33 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Hologic
10 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

McKesson has higher revenue and earnings than Hologic. Hologic is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
McKesson$359.05B0.25$3.30B$25.8327.52
Hologic$4.03B3.54$789.50M$2.3727.01

Summary

McKesson and Hologic tied by winning 8 of the 16 factors compared between the two stocks.

Get McKesson News Delivered to You Automatically

Sign up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MCK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MCK vs. The Competition

MetricMcKessonMED/DENTAL IndustryMedical SectorNYSE Exchange
Market Cap$89.55B$15.49B$5.57B$20.75B
Dividend Yield0.40%1.46%3.80%3.66%
P/E Ratio27.5218.3319.8925.75
Price / Sales0.252.29441.5059.30
Price / Cash18.4216.9435.8422.13
Price / Book-52.583.788.264.66
Net Income$3.30B$430.42M$3.24B$994.58M
7 Day Performance-0.45%-1.88%0.50%-0.69%
1 Month Performance-1.88%4.10%7.99%5.41%
1 Year Performance22.07%14.78%28.68%9.18%

McKesson Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MCK
McKesson
4.5881 of 5 stars
$710.87
-0.7%
$710.17
-0.1%
+22.5%$89.55B$359.05B27.5245,000Positive News
Analyst Forecast
Insider Trade
HOLX
Hologic
4.7141 of 5 stars
$64.62
-1.7%
$78.75
+21.9%
-18.6%$14.40B$4.03B27.277,063Positive News
Analyst Forecast
HQY
HealthEquity
3.205 of 5 stars
$97.34
+3.0%
$118.55
+21.8%
+19.9%$8.42B$1.20B71.053,120Positive News
Analyst Revision
HSIC
Henry Schein
4.0845 of 5 stars
$70.68
-3.7%
$78.36
+10.9%
+2.6%$8.60B$12.67B22.0925,000News Coverage
Analyst Downgrade
Analyst Revision
MMSI
Merit Medical Systems
4.6602 of 5 stars
$93.45
0.0%
$109.11
+16.8%
-3.6%$5.52B$1.36B45.817,400Analyst Forecast
AMN
AMN Healthcare Services
4.3714 of 5 stars
$20.72
-2.1%
$32.08
+54.8%
-65.0%$793.27M$2.85B-4.792,968Analyst Revision
CRL
Charles River Laboratories International
4.7268 of 5 stars
$158.09
-0.8%
$174.54
+10.4%
-31.9%$7.77B$4.05B-243.2120,100News Coverage
Positive News
HUM
Humana
4.8451 of 5 stars
$227.13
-1.5%
$280.76
+23.6%
-42.7%$27.41B$117.76B16.0665,680Analyst Forecast
ITGR
Integer
3.8812 of 5 stars
$119.61
-0.3%
$145.00
+21.2%
-6.0%$4.17B$1.72B56.6911,000News Coverage
Positive News
Upcoming Earnings
WST
West Pharmaceutical Services
4.8068 of 5 stars
$224.66
-1.1%
$320.00
+42.4%
-31.8%$16.14B$2.89B35.2710,600Positive News
Upcoming Earnings
COR
Cencora
4.4821 of 5 stars
$297.00
+0.6%
$306.33
+3.1%
+32.1%$57.57B$638.56M34.4546,000Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:MCK) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners